Nanae Matsuo

Clinical impact of a combined therapy of peritoneal dialysis and hemodialysis

Nanae Matsuo, K Yokoyama, Yukitaka Maruyama et al. · Clinical Nephrology · 2010 · 43 citations

Medicine, Nephrology, Pharmacotherapy +17

Survival rate and risk factors for patients with retinoblastoma in Japan

Yukari Uemura, Hideki Matsuda, M. Tamai et al. · Japanese Journal of Ophthalmology · 1992 · 39 citations

Medicine, Oncology, Ophthalmology +13

Serum ?2 microglobulin (?2MG) level is a potential predictor for encapsulating peritoneal sclerosis (EPS) in peritoneal dialysis patients

Keitaro Yokoyama, H. Yoshida, Nanae Matsuo et al. · Clinical Nephrology · 2008 · 33 citations

Medicine, Nephrology, Dialysis +11

A lower level of reduced albumin induces serious cardiovascular incidence among peritoneal dialysis patients

Hiroyuki Terawaki, Yukie Matsuyama, Nanae Matsuo et al. · Clinical and Experimental Nephrology · 2012 · 32 citations

Medicine, Nephrology, Dialysis +13

Relationship Between the −374T/A Receptor of Advanced Glycation End Products Gene Polymorphism and Peritoneal Solute Transport Status at the Initiation of Peritoneal Dialysis

Yukio Maruyama, Miwako Numata, Masaaki Nakayama et al. · Therapeutic Apheresis and Dialysis · 2007 · 20 citations

Medicine, Molecular Genetics, Nephrology +14